[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371778-105":59,"doc-detail-371778-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-novel-cell-death-mechanisms-in-breast-cancer-intersecting-perspectiveson-ferroptosis-cuproptosis-disulfidptosis-and-pyroptosis","Advances in novel cell death mechanisms in breast cancer - intersecting perspectiveson ferroptosis, cuproptosis, disulfidptosis, and pyroptosis","","Molecular classification has ushered breast cancer treatment into an era of precision medicine, yet clinical management remains hindered by drug resistance and tumor heterogeneity. This review highlights ferroptosis, cuproptosis, disulfidptosis, and pyroptosis as key programmed cell death regulators of tumor progression, therapeutic responsiveness, and immune microenvironment remodeling. It details mechanistic foundations and molecular regulatory networks, and evaluates existing targeted interventions alongside their potential for clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-novel-cell-death-mechanisms-in-breast-cancer-intersecting-perspectiveson-ferroptosis-cuproptosis-disulfidptosis-and-pyroptosis/371778/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-novel-cell-death-mechanisms-in-breast-cancer-intersecting-perspectiveson-ferroptosis-cuproptosis-disulfidptosis-and-pyroptosis/371778.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problems motivate this review on breast cancer cell death mechanisms?","Question",{"text":112,"@type":113},"Drug resistance and tumor heterogeneity continue to challenge clinical management despite advances in molecular classification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which non-apoptotic programmed cell death pathways are emphasized?",{"text":117,"@type":113},"The review focuses on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis as regulators of breast cancer progression and immune remodeling.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the review connect these pathways to therapy?",{"text":121,"@type":113},"It examines mechanistic and regulatory networks and evaluates current targeted intervention strategies for their therapeutic potential and clinical translation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371778,1790400052,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Jing et al. Molecular Cancer (2025) 24:224 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02445-0](https://doi.org/10.1186/s12943-025-02445-0)  \nREVIEW Open Access  \nAdvances in novel cell death mechanisms in breast cancer: intersecting perspectiveson ferroptosis, cuproptosis, disulfidptosis, and pyroptosis  \nZhengjun Jing 1†, Wenqin Huang2†, Jun Mei3†, Sudhanshu Bhushan4, Xinhong Wu2*, Chengbiao Yan5*, Hongmei Zheng2* andYalong Yang2*  \nAbstract  \nThe advent of molecular classification has ushered breast cancer treatment into the era of precision medicine. Nevertheless, clinical management continues to face significant challenges posed by drug resistance and tumor heterogeneity. Recent advances have identified novel programmed cell death (PCD) mechanisms-including ferroptosis, cuproptosis, disulfidptosis, and pyroptosis-as critical regulators of breast cancer progression, therapeutic responsiveness, and immune microenvironment remodeling. This review systematically elucidates the mechanistic foundations of these PCD pathways and investigates their molecular regulatory networks within breast cancer pathogenesis. Furthermore, we evaluate current targeted intervention strategies and assess their clinical translation potential, ultimately providing a theoretical framework for pioneering therapeutic approaches.  \nKeywords Breast cancer, Programmed cell death, Ferroptosis, Cuproptosis, Disulfidptosis, Pyroptosis  \n†Zhengjun Jing, Wenqin Huang and Jun Mei contributed equally.  \n*Correspondence: XinhongWu [wuxinhong_9@sina.com](wuxinhong_9@sina.com)[ ](wuxinhong_9@sina.com)Chengbiao Yan [522023252@qq.com](522023252@qq.com)[ ](522023252@qq.com)Hongmei Zheng [2022ZL0002@hust.edu.cn](2022ZL0002@hust.edu.cn)[ ](2022ZL0002@hust.edu.cn)Yalong Yang [yalong.yang@whu.edu.cn](yalong.yang@whu.edu.cn)  \n1Department of Thyroid and Breast Surgery, Gong’an County People’s Hospital, Gong’an County 434300, Hubei Province, China  \n2Department of Breast Surgery, Breast Cancer Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan 430079, Hubei, China  \n3Department of Thyroid and Breast Surgery, Huanggang Central Hospital, Huanggang City 438000, Hubei Province, China  \n4Department of Anatomy and Cell Biology, Unit of Reproductive Biology, Justus-Liebig-University Giessen, 35392 Giessen, Germany 5Department of Surgery, Jianli Hospital of Traditional Chinese Medicine, Jianli City 433300, Hubei Province, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nJing et al. Molecular Cancer (2025) 24:224  \nIntroduction  \nBreast cancer is the most prevalent malignancy in terms of both incidence and mortality among women worldwide. According to the GLOBOCAN 2022 data released by the Interna","cbCaibAAx8FMsqfu","https://ap.wps.com/l/cbCaibAAx8FMsqfu","pdf",2541735,"English","# Introduction\n# Non-apoptotic PCD mechanisms overview\n## Table 1: Key regulatory molecules and targeted drugs","[{\"question\":\"What clinical problems motivate this review on breast cancer cell death mechanisms?\",\"answer\":\"Drug resistance and tumor heterogeneity continue to challenge clinical management despite advances in molecular classification.\"},{\"question\":\"Which non-apoptotic programmed cell death pathways are emphasized?\",\"answer\":\"The review focuses on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis as regulators of breast cancer progression and immune remodeling.\"},{\"question\":\"How does the review connect these pathways to therapy?\",\"answer\":\"It examines mechanistic and regulatory networks and evaluates current targeted intervention strategies for their therapeutic potential and clinical translation.\"}]","Advances in novel cell death mechanisms in breast cancer - intersecting perspectiveson ferroptosis, cuproptosis, disulfidptosis, and pyroptosis | PDF",1790192845,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3a3692f92ca1cfbfded160627033107.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50166327fcf29e2afbfef4f8eeb2d858.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bea9d0570e25ff7d59064ce57099d2b.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16147ad9714fbe8ced10a2bbe4829c75.webp",980,1306]